Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.
NCT00298350
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
278
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV
HIV-1
Human Immunodeficiency Virus
Interventions
DRUG:
GS-9137 - A Novel HIV-1 Integrase Inhibitor
Sponsor
Gilead Sciences